Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

Jemal, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322/caac.20107 Cuzick, 1985, Tamoxifen and contralateral breast cancer, Lancet, 2, 282, 10.1016/S0140-6736(85)90338-1 Fisher, 2005, Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study, J Natl Cancer Inst, 97, 1652, 10.1093/jnci/dji372 Fisher, 1998, Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study, J Natl Cancer Inst, 90, 1371, 10.1093/jnci/90.18.1371 Powles, 2007, Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial, J Natl Cancer Inst, 99, 283, 10.1093/jnci/djk050 Cuzick, 2002, First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial, Lancet, 360, 817, 10.1016/S0140-6736(02)09962-2 Cuzick, 2007, Long-term results of tamoxifen prophylaxis for breast cancer–96-month follow-up of the randomized IBIS-I trial, J Natl Cancer Inst, 99, 272, 10.1093/jnci/djk049 Veronesi, 2003, Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women, J Natl Cancer Inst, 95, 160, 10.1093/jnci/95.2.160 Powles, 1998, Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial, Lancet, 352, 98, 10.1016/S0140-6736(98)85012-5 Cuzick, 2013, Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data, Lancet, 381, 1827, 10.1016/S0140-6736(13)60140-3 Veronesi, 1998, Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study, Lancet, 352, 93, 10.1016/S0140-6736(98)85011-3 Veronesi, 2007, Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy, J Natl Cancer Inst, 99, 727, 10.1093/jnci/djk154 Cuzick, 2014, Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial, Lancet, 383, 1041, 10.1016/S0140-6736(13)62292-8 Cox, 1984 Cox, 1972, Regression models and life tables, J R Stat Soc, 34, 187 Schoenfeld, 1980, Chi-squared goodness-of-fit tests for the proportional hazard regression model, Biometrika, 67, 145, 10.1093/biomet/67.1.145 Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Davies, 2011, Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials, Lancet, 378, 771, 10.1016/S0140-6736(11)60993-8 Cuzick, 2003, Overview of the main outcomes in breast-cancer prevention trials, Lancet, 361, 296, 10.1016/S0140-6736(03)12342-2